Metformin may reduce delirium risk and mortality in people with type 2 diabetes
Diabetes,
Researchers have been looking for a link between diabetes and delirium since delirium is more prevalent in dementia patients…
メトホルミンで糖尿病のせん妄抑制 22年12月 6日 医療ニュース 612 15
Medical Tribune,
612名の医師が参考になったと回答 米・Stanford University School of Medicineの山梨豪彦氏らは、2型糖尿病患者に対するメトホルミンの投与がせん妄および死亡率に及ぼす影響を検討するため、2型糖尿病患者506例を対象に後ろ向…
The potential benefit of metformin to reduce delirium risk and mortality
Today UK News,
Prevalence of delirium by comparing three patient groups based on their DM status and history of metformin use.
Aging | The potential benefit of metformin to reduce delirium risk and
ScienMag,
“In this report, we showed the potential benefit of metformin in decreasing the risk of delirium and mortality in DM [diabetes…
Aging | The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study
EurekAlert!,
In this report, we showed the potential benefit of metformin in decreasing the risk of delirium and mortality in DM [diabetes…
Aging | The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study
Bioengineer.org,
“In this report, we showed the potential benefit of metformin in decreasing the risk of delirium and mortality in DM [diabetes…
Press | Aging
Aging-US News,
12-07-2022 “In this report, we showed the potential benefit of metformin in decreasing the risk of delirium and mortality in DM …